Results
Balaxi Pharmaceuticals Q2 Net Profit Drops 97% YoY
Balaxi reported Q2 standalone net profit of ₹10.60 lakhs, a 97% YoY decline from ₹326.36 lakhs, despite revenue growth to ₹2,628.57 lakhs.
The company received WHO-GMP certification for its Hyderabad
